Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2011; 17(46): 5059-5074
Published online Dec 14, 2011. doi: 10.3748/wjg.v17.i46.5059
Published online Dec 14, 2011. doi: 10.3748/wjg.v17.i46.5059
Author | Yr | n | Discriminatingfactor | Sensitivity (%) | Specificity (%) |
PET | PET | ||||
De Potter et al[85] | 2002 | 33 | 70 | 69 | |
Jadvar et al[90] | 2003 | 16 | 94 | 100 | |
Yoshioka et al[75] | 2003 | Liver | 78-85 | 82-74 | |
Lung | 67 | 88 | |||
Bone | 30 | 82 | |||
Pleural | 4 | 100 | |||
Ascites | 24 | 76 | |||
Patriti et al[89] | 2007 | 51 | 100 | ||
Nakamoto et al[88] | 2009 | 44 | Previous suspicious imaging | 80 | 100 |
14 | Tumor markers positive | 73 | 83 | ||
26 | Routine | 50 | 88 | ||
Park et al[117] | 2009 | 105 | 75 | 77 | |
Sim et al[86] | 2009 | 52 | 68.40 | 71.40 | |
Sohn et al[118] | 2009 | 212 | Post ablation | 0 |
- Citation: Smyth EC, Shah MA. Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies. World J Gastroenterol 2011; 17(46): 5059-5074
- URL: https://www.wjgnet.com/1007-9327/full/v17/i46/5059.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i46.5059